Intrahepatic endothelial and Kupffer cells involved in immunosuppressive cytokines and natural killer (NK)/NK T cell disorders in viral acute hepatitis

Clinical and Experimental Immunology

Volumn 152, Issue 2, 2008, Pages 298-310

  Jacques, A ^a   Bleau, C ^a   Martin, J P ^b   Lamontagne, L ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b INSTITUT PASTEUR   (France)

Author keywords

Immunosuppressive cytokines; MHV3; NK NK T cells; Pathogenicity

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; PROSTAGLANDIN E2; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ACUTE HEPATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ATTENUATION; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENDOTHELIUM; FEMALE; IMMUNOLOGICAL TOLERANCE; KUPFFER CELL; LIVER; LIVER SINUSOID; MONONUCLEAR CELL; MOUSE; MURINE HEPATITIS CORONAVIRUS; NATURAL KILLER T CELL; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; VIRUS HEPATITIS; VIRUS REPLICATION;

ANIMALS; CELLS, CULTURED; CYTOKINES; ENDOTHELIUM, VASCULAR; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HEPATITIS, VIRAL, ANIMAL; IMMUNE TOLERANCE; INTERFERON TYPE II; INTERLEUKIN-4; KILLER CELLS, NATURAL; KUPFFER CELLS; LIVER; MICE; MICE, INBRED C57BL; MURINE HEPATITIS VIRUS; T-LYMPHOCYTE SUBSETS; VIRULENCE;

EID: 42049119877     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03628.x     Document Type: Article

References (35)

1. Kimura K, Kakimi K, Wieland S, Guidotti LG, Chisari FV. Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice. J Immunol 2002 169 : 5188 95.
2. Uhrig A, Banafsche R, Kremer M et al. Development and functional consequences of LPS tolerance in sinusoidal endothelial cells of the liver. J Leukoc Biol 2005 77 : 626 33.
3. Knolle PA, Uhrig A, Hegenbarth S et al. IL-10 down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells through decreased antigen uptake via the mannose receptor and lowered surface expression of accessory molecules. Clin Exp Immunol 1998 114 : 427 33.
4. Bissel DM, Wang SS, Jarnagin WR, Roll FJ. Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest 1995 96 : 447 55.
5. Hammond KJ, Pelikan SB, Crowe NY et al. NK-T cells are phenotypically and functionnaly diverse. Eur J Immunol 1999 29 : 3768 81.
6. Gansuvd B, Hagihara M, Yu Y, Inoue H, Ueda Y, Tsuchiya T et al. Human umbilical cord blood NK T cells kill tumors by multiple cytotoxic mechanisms. Hum Immunol 2002 63 : 164 75.
7. Jonuleit H, Schmitt E, Kakirman H, Stassen M, Knop J, Enk AH. Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J Exp Med 2002 196 : 255 60.
8. Bolacchi F, Sinistro A, Ciaprini C et al. Increased hepatitis C virus (HCV)-specific CD4+CD25+ regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels. Clin Exp Immunol 2006 144 : 188 96.
9. MacDonald HR. Development and selection of NK-T cells. Curr Opin Immunol 2002 14 : 250 4.
10. Mallevaey T, Fontaine J, Breuilh L et al. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis. Infect Immun 2007 75 : 2171 80.
11. Giroux M, Denis F. CD1d-unrestricted human NK-T cells release chemokines upon Fas engagement. Blood 2005 105 : 703 10.
12. Kimura K, Kakimi K, Wieland S, Guidotti LG, Chisari FV. Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice. J Virol 2002 76 : 10702 7.
13. Guidotti LG, Chisari FV. Non cytolytic control of viral infections by the innate and adaptative immune response. Annu Rev Immunol 2001 19 : 65 91.
14. Seki S, Osada S, Ono S et al. Role of liver NK cells and peritoneal macrophages in gamma interferon and interleukin-10 production in experimental bacterial peritonitis in mice. Infect Immun 1998 66 : 5286 94.
15. Roland J, Soulard V, Sellier C et al. NK cell responses to Plasmodium infection and control of intrahepatic parasite development. J Immunol 2006 177 : 1229 39.
16. Exley MA, He Q, Cheng O et al. Cutting edge: compartmentalization of Th1-like noninvariant CD1d-reactive T cells in hepatitis C virus-infected liver. J Immunol 2002 168 : 1519 23.
17. Ajuebor MN, Aspinall AI, Zhou F et al. Lack of chemokine receptor CCR5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1d-restricted NK-T cells. J Immunol 2005 174 : 8027 37.
18. Biburger M, Tiegs G. Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells. J Immunol 2005 175 : 1540 50.
19. Paladino N, Flores AC, Marcos CY et al. Increased frequencies of activating natural killer receptors are associated with liver injury in individuals who do not eliminate hepatitis C virus. Tissue Antigens 2007 69 : 109 11.
20. Simon AK, Jones E, Richards H et al. Regulatory cells inhibit Fas-ligand induced innate and adaptative tumor immunity. Eur J Immunol 2007 37 : 758 67.
21. Ralainirina N, Poli A, Michel T et al. Control of NK cell functions by CD4+CD25+ regulatory cells. Immunology 2007 120 : 73 82.
22. Brillard E, Pallandre JR, Chalmers D et al. Natural killer cells prevent CD28-mediated FoxP3 transcription in CD4+CD25- T lymphocytes. Exp Hematol 2007 35 : 416 25.
23. Le Prevost C, Levy-Leblond E, Virelizier JL, Dupuy JM. Immunopathology of mouse hepatitis virus type 3 infection. I. Role of humoral and cell-mediated immunity in resistance mechanism. J Immunol 1975 114 : 221 5.
24. Dupuy JM, Levy-Leblond E, Le Prevost C. Immunopathology of mouse hepatitis virus type 3 infection. II. Effect of immunosuppression in resistant mice. J Immunol 1975 114 : 226 30.
25. Martin JP, Chen W, Koehren F, Pereira CA. The virulence of mouse hepatitis virus 3, as evidenced by permissivity of cultured hepatic cells toward escaped mutants. Res Virol 1994 145 : 297 302.
26. Lamontagne L, Page C, Braunwald J, Martin JP. Pathogenicity of neutralization escape mutants of mouse hepatitis virus: correlation with T- and B-cell depletions. Res Immunol 1994 145 : 553 65.
27. Lamontagne L, Dupuy JM. Persistent infection with mouse hepatitis virus 3 in mouse lymphoid cell lines. Infect Immunol 1984 44 : 716 23.
28. Lehoux M, Jacques A, Lusignan S, Lamontagne L. Murine viral hepatitis involves NK cell depletion associated with virus-induced apoptosis. Clin Exp Immunol 2004 137 : 41 51.
29. Stohlman SA, Brayton PR, Harmon RC, Stevenson D, Ganges RG, Matsushima GK. Natural killer cell activity during mouse hepatitis virus infection: response in the absence of interferon. Int J Cancer 1983 31 : 309 14.
30. Dupuy JM, Rodrigue D. Heterogeneity in evolutive patterns of inbred mice infected with a cloned substrain of mouse hepatitis virus type 3. Intervirology 1981 16 : 114 17.
31. Watanabe H, Ohtsuka K, Kimura M et al. Details of an isolation method for hepatic lymphocytes in mice. J Immunol 1992 146 : 145 54.
32. Lamontagne L, Massicotte E, Page C. Mouse hepatitis viral infection induces and extrathymic differentiation of the specific intrahepatic alpha beta-TCRintermediate LFA-1high T-cell population. Immunology 1997 90 : 402 10.
33. Schröder M, Meisel C, Buhl K et al. Different modes of IL-10 and TGF-β to inhibit cytokine-dependent IFN-γ production: consequences for reversal of lipopolysaccharide desensitization. J Immunol 2003 170 : 5260 7.
34. Lamontagne L, Descoteaux JP, Jolicoeur P. Mouse hepatitis virus 3 replication in T and B lymphocytes correlate with viral pathogenicity. J Immunol 1989 142 : 4458 65.
35. Abecassis M, Falk J, Dindzans V et al. Prostaglandin E2 prevents fulminant hepatitis and the induction of procoagulant activity in susceptible animals. Transplant Proc 1987 19 : 1103 5.